The University of Chicago Header Logo

Connection

Michael Charlton to MAP Kinase Kinase Kinase 5

Back to Details
This is a "connection" page, showing publications Michael Charlton has written about MAP Kinase Kinase Kinase 5.
Michael Charlton
Connection Strength
0.200
MAP Kinase Kinase Kinase 5
  1. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology. 2018 02; 67(2):549-559.
    View in: PubMed
    Score: 0.159
  2. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver Int. 2018 10; 38(10):1849-1859.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.